This recording focuses on one of the most critical, and often overlooked, stages of the journey: post-sale transition and support.
We are joined by Jack Knight, Managing Director of Xiel, a specialist distributor of radiotherapy and nuclear medicine technologies. S&W supported Jack as a shareholder through the successful sale of Xiel to MIS Healthcare, backed by private equity firm H2 Equity Partners. Jack has remained at the helm, continuing to lead and grow the business under private equity ownership.
Jack shares first-hand insights and practical lessons from navigating a private equity transaction and operating under new ownership – offering an honest perspective on what really happens after the deal is done.
Time & Location
10 June 2026
12 - 1pm
Agenda
Our panel discusses
- Managing the transition period and fulfilling handover obligations
- Life after an earn-out or deferred consideration
- Tax implications and how to manage your proceeds effectively
- Protecting your wealth and planning for long-term and succession goals
- Shaping your next chapter – whether that’s retirement, a new venture or a portfolio career
- Building relationships with the acquiring company and navigating post-merger integration
- Avoiding common post-sale challenges and regrets
Our speakers
-
View profileLaura Hayward
Partner
-
View profileLynne Blakey
Partner
-
View profilePaul Stagg
Director
-
Jack Knight
Managing Director, Xiel